Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
0.00%
OPERATING MARGIN AVG 3Y
0.00%
OPERATING MARGIN AVG 5Y
0.00%
OPERATING MARGIN AVG 10Y
0.00%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Market Cap
$2.17B
Operating Margin
-3.63%
TTM Avg
-47.27%
3Y Avg
-10.12%
5Y Avg
11.86%
Market Cap
$2.13B
Operating Margin
-2.76%
TTM Avg
-5.18%
3Y Avg
-96.00%
5Y Avg
-121.53%
Market Cap
$2.24B
Operating Margin
-42.22%
TTM Avg
-21.11%
3Y Avg
-21.11%
5Y Avg
-21.11%
Market Cap
$2.11B
Operating Margin
10.04%
TTM Avg
9.32%
3Y Avg
8.61%
5Y Avg
7.98%
Market Cap
$2.11B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.11B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1048.75%
5Y Avg
-903.60%
Market Cap
$2.28B
Operating Margin
24.03%
TTM Avg
25.35%
3Y Avg
27.79%
5Y Avg
25.07%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pharvaris N.V. (PHVS) | $2.17B | 0.00% | 0.00% | 0.00% | 0.00% |
| Maravai LifeSciences Holdings, Inc. (MRVI)vs › | $2.17B | -3.63% | -47.27% | -10.12% | 11.86% |
| GeneDx Holdings Corp. (WGS)vs › | $2.13B | -2.76% | -5.18% | -96.00% | -121.53% |
| Alamar Biosciences, Inc. (ALMR)vs › | $2.24B | -42.22% | -21.11% | -21.11% | -21.11% |
| Addus HomeCare Corporation (ADUS)vs › | $2.11B | 10.04% | 9.32% | 8.61% | 7.98% |
| Vera Therapeutics, Inc. (VERA)vs › | $2.11B | 0.00% | 0.00% | 0.00% | 0.00% |
| SELLAS Life Sciences Group, Inc. (SLS)vs › | $2.11B | 0.00% | 0.00% | -1048.75% | -903.60% |
| Alvotech (ALVO)vs › | $2.08B | 9.62% | 13.78% | -194.45% | -270.76% |
| Harmony Biosciences Holdings, Inc. (HRMY)vs › | $2.28B | 24.03% | 25.35% | 27.79% | 25.07% |
| Viridian Therapeutics, Inc. (VRDN)vs › | $2.06B | -512.91% | -49765.56% | -47036.35% | -33558.09% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-04-30 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
